SOLIGENIX, INC. (SNGX): Nasdaq/NYSE listing notice — Soligenix gets Nasdaq extension to May 15, 2023 for equity listing compliance

SOLIGENIX, INC.

Nasdaq extended the deadline to regain Shareholders' Equity Requirement compliance from March 31, 2023 to May 15, 2023.
Company had previously satisfied the Minimum Bid Price Requirement on February 24, 2023.
No assurance that Soligenix will meet the equity requirement by the new deadline or remain listed.
Failure to comply could lead to delisting from Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SOLIGENIX, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

April 6, 2023, Nasdaq granted the Company’s request for an extension of the deadline by which it must regain compliance with the Shareholders’ Equity Requirement from March 31, 2023 to May 15, 2023. The Company is working diligently to satisfy, and intends to regain compliance with, the Shareholders’ Equity Requirement; however, there can be no assurance that the Company will be able to do so prior to the deadline established by Nasdaq, or at all, or that the Company’s common stock will remain listed on The Nasdaq Capital Market. Safe Harbor for Forward-Looking Statements Certain statement

View on SEC.gov

Browse all listing & compliance notices →

SOLIGENIX, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-005653

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.